Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-6-11
pubmed:abstractText
Cisplatin-based chemoradiation for locally advanced cervical carcinoma is now the standard of care for most patients with cervical carcinoma. However, induction chemotherapy followed by surgery, particularly with newer agents or combinations remains to be explored. This study was undertaken to evaluate the antitumor activity and toxicity of gemcitabine in combination with cisplatin for untreated locally advanced cervical carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
541-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11398890-Adenocarcinoma, pubmed-meshheading:11398890-Adolescent, pubmed-meshheading:11398890-Adult, pubmed-meshheading:11398890-Aged, pubmed-meshheading:11398890-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11398890-Carcinoma, Adenosquamous, pubmed-meshheading:11398890-Carcinoma, Squamous Cell, pubmed-meshheading:11398890-Cisplatin, pubmed-meshheading:11398890-Deoxycytidine, pubmed-meshheading:11398890-Disease-Free Survival, pubmed-meshheading:11398890-Female, pubmed-meshheading:11398890-Humans, pubmed-meshheading:11398890-Middle Aged, pubmed-meshheading:11398890-Neoadjuvant Therapy, pubmed-meshheading:11398890-Neoplasm Staging, pubmed-meshheading:11398890-Survival Rate, pubmed-meshheading:11398890-Treatment Outcome, pubmed-meshheading:11398890-Uterine Cervical Neoplasms
pubmed:year
2001
pubmed:articleTitle
A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.
pubmed:affiliation
Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico. alduenas@dfl.telmex.net.mx
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II